Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Plastics to Oil - Pyrolysis and Secret Catalysts and Alterna -- Ignore unavailable to you. Want to Upgrade?

To: SteveF who wrote (20106)	3/13/2012 7:14:50 PM
From: scion	Respond to of 53574

Yes, it's a mistake by the SEC filer. I expect it will be rectified soon.

To: SteveF who wrote (20106)	3/13/2012 7:27:01 PM
From: scion	Respond to of 53574

SEC v. United American Ventures, LLC, et al Posted by Pinnacle Trust on January 17, 2012 msfiduciary.com The SEC filed charges alleging that two companies and four individuals misrepresented and concealed numerous material facts in connection with the offer and sale of $10 million in bonds to approximately 100 individual investors in various states. In particular, the SEC alleged that the defendants promised guaranteed returns in purported investments in medical technologies and raised money by convincing investors to invest through self-directed IRAs and steering them to custodians who offered the self-directed IRAs. Approximately $3.5 million of the funds invested in the bonds came from self-directed IRAs. The SEC’s complaint alleges that the defendants misrepresented and concealed numerous material facts in communications with investors. They assured investors, for example, that UAV had a strong track record of profiting from medical-related investments and that investors would earn a guaranteed 25 percent annual return on UAV’s bonds. In reality, UAV had no such record or experience, and never earned a return from any investment. Instead, UAV used nearly all of the money it raised from investors for purposes other than investments in medical ventures, such as paying exorbitant salaries and benefits, paying referral fees, and making Ponzi-type interest payments to investors. Further, the defendants misrepresented their venture capital experience and educational background, and failed to inform investors that one of the principals was previously barred by a California court from being involved in any securities offering. To read the full complaint, click here. sec.gov msfiduciary.com